StocksNeurocrine Biosciences IncNBIX

NBIX

Neurocrine Biosciences Inc

96.16 1.31 (1.38%)
Zdržení NASDAQ při tvorbě cen, v USD Trh se uzavřel
Obchodovat
S
95.91
B
96.19

Neurocrine Biosciences Inc

Poslední měsíc
6,142
Sledující
2.58%
Investoři
100% Of them have BUY positions.
A decrease of -1.01% from last trading Day

Související trhy

Swedish Match AB
SWMA.ST
-13.64 (-1.88%)
S
710.56
B
712.04
Carnival
CCL.L
-113.50 (-6.91%)
S
1528.82
B
1532.98
CNX Resources Corp
CNX
-0.30 (-2.17%)
S
13.46
B
13.49
Orpea
ORP.PA
-1.13 (-1.03%)
S
107.50
B
107.75
ViacomCBS Inc.
VIAC
-0.48 (-1.25%)
S
37.88
B
37.95
Zobrazit více

Investoři

Zobrazit více
Top
Anthony Sofocleous
𝙋𝘼𝙍𝙏 𝙏𝙒𝙊 GLUU - (HOLD) – (UNDERVALUED) Long term price target $12.50 - Support $12.44 - Latest total news was neutral - Sector software - Sales growth last 12 months up 25% (Excellent) 1-3 years sales growth forecast up 30% (Excellent) GOLD - (STRONG BUY) – (UNDERVALUED) Long term price target... Zobrazit více Přeložit
Axel De La Harpe
Opraveno
𝐌𝐢𝐬𝐬𝐢𝐧𝐠 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐨𝐧 𝐄𝐭𝐨𝐫𝐨 I believe there are several great platform biotech/healthcare stocks that are not yet tradable on Etoro which results in lost opportunities for people investing via the Etoro platform. I have made a request to... Zobrazit více Přeložit
Francisco Javier Martinez Lago
Opraveno
Todays' pre-market is looking positively green. Here's just a preview of some stocks in our portfolio: - $YNDX (Yandex NV): +3.94% - $NBIX (Neurocrine Biosciences Inc): +3.26% - $NIO (Nio Inc.): +2.52% - $TSLA (Tesla Motors, Inc.): +2.17% - $FROG (Jfrog Ltd): +1.67% Needless to say, pre-market... Zobrazit více Přeložit
Líbí KomentářSdílet
null
.
Mathew Ellison
Spojené království
Some strong pre-market moves for the portfolio, $NBIX (Neurocrine Biosciences Inc) leading the pack at 3.2% with $SNOW (Snowflake Inc.) coming in second at 1.5%. Very little draw down at the bottom, $WMT (Wal-Mart) worst performer pre-market at -0.24% We added 2.4% yesterday and have freed up 6% equity... Zobrazit více Přeložit
Anthony Sofocleous
𝙋𝘼𝙍𝙏 𝙏𝙒𝙊 GLUU - (HOLD) – (UNDERVALUED) Long term price target $12.50 - Support $12.45 - Latest total news was neutral - Sector software - Sales growth last 12 months up 25% (Excellent) 1-3 years sales growth forecast up 30% (Excellent) GOLD - (STRONG BUY) – (UNDERVALUED) Long term price target... Zobrazit více Přeložit
Líbí KomentářSdílet
1 odpověď
null
.